Abstract
Recently we proposed and tested a novel framework based on information theory about the features of agrammatism in patients with the nonfluent variant of primary progressive aphasia (nfvPPA). These features include short sentences, simplified structures, the omission of function words, reduced use of verbs, and increased use of heavy verbs. After distinguishing the syntactic and lexical features of agrammatism, we proposed that the lexical features are not defects but rather a compensatory response to structural deficits. We showed that although patients with nfvPPA have difficulty using complex structures, they use more informative words to facilitate the transfer of their intended message. In this work, we demonstrated the generalizability of our findings to patients with Broca’s aphasia who share similar neuroanatomical involvements with patients with nfvPPA. We found that patients with Broca’s aphasia use simpler syntactic structures as measured by higher syntax frequency. We also found that the use of simpler syntax predicts the use of lower-frequency words. Furthermore, our study showed that producing sentences of lower word frequency is likely achieved through the canonical features of agrammatism, i.e., higher proportions of content words over function words, nouns over verbs, and heavy verbs over light verbs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Nothing to declare
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
AphasiaBank
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data is available through the AphasiaBank
